Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pseudoephedrine for Prevention of Middle Ear Barotrauma in HBOT
NCT04332211Phase 4Completed
- Sponsor
- University of Maryland, Baltimore
- Start
- May 2021
- Primary completion
- Jul 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of pseudoephedrine in Middle ear barotrauma (MEBT), sponsored by University of Maryland, Baltimore. Started May 2021; status: completed.
02
Drugs
pseudoephedrine
03
Conditions
Middle ear barotrauma (MEBT)
Beyond the preview
Go deeper on NCT04332211.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04332211.